490.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$478.12
Offen:
$472.87
24-Stunden-Volumen:
1.80M
Relative Volume:
0.79
Marktkapitalisierung:
$182.13B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
27.64
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
+3.55%
1M Leistung:
-5.06%
6M Leistung:
+4.59%
1J Leistung:
-5.85%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
490.28 | 177.61B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.09 | 134.36B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
570.21 | 46.06B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
114.20 | 31.66B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
301.94 | 29.61B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific Inc. 8-K Filing Details and Registered Securities Listing March 2026 - Minichart
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc. - pharmiweb.com
Thermo Fisher Scientific (TMO) Completes Acquisition of Clario H - GuruFocus
Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial - Yahoo Finance UK
Thermo Fisher Scientific Inc. completed the acquisition of Clario Holdings, Inc. from a shareholder group led by Nordic Capital, Novo Holdings A/S, Astorg Asset Management S A.R.L., Cinven Limited and Partners Group Private Equity Limited, managed by Par - marketscreener.com
Thermo Fisher (TMO) Completes Acquisition of Clario Holdings - GuruFocus
Thermo Fisher Completes Strategic Acquisition of Clario Holdings - TipRanks
Thermo Fisher completes $8.9B acquisition of Clario - Investing.com
Thermo Fisher completes $8.875B acquisition of Clario to boost clinical data offerings - TradingView
Thermo Fisher (NYSE: TMO) closes $8.875B Clario deal with EPS accretion - Stock Titan
Nordea Investment Management AB Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
E. Ohman J or Asset Management AB Has $53.93 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Community Trust & Investment Co. Decreases Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Carderock Capital Management Inc. Buys 5,662 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher’s Fluid Ease Pro ClipTip puts a touchscreen on the electronic pipette - R&D World
Thermo Fisher Scientific stock faces pressure amid shifting life sciences demand - AD HOC NEWS
Thermo Fisher Scientific Achieves New Milestone in AI-Driven Diagnostics with Advanced Microscopy In - AD HOC NEWS
Is Thermo Fisher Scientific (TMO) Pricing Look Attractive After Recent Share Price Weakness - Yahoo Finance
Sarasin & Partners LLP Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Aug Action: Is Thermo Fisher Scientific Inc stock forming a triangle patternWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Thermo Fisher Scientific supports Swindon with place-marketing campaign - Rayo
EU Commission clears acquisition of Clario by Thermo Fisher - INSIGHT EU MONITORING
Thermo Fisher Scientific Gains EU Approval for Clario Acquisition: Boost to Clinical Trial Capabilit - AD HOC NEWS
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Union Bancaire Privee UBP SA Has $30.76 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
EU Clears Thermo Fisher's Multibillion-Dollar Clario Acquistion - marketscreener.com
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 MillionAnalysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More - Yahoo Finance
Confluence Investment Management LLC Acquires 11,841 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Argent Capital Management LLC Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Mirova Trims Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Groupama Asset Management Boosts Thermo Fisher Scientific Holdings - National Today
Groupama Asset Managment Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
52,093 Shares in Thermo Fisher Scientific Inc. $TMO Acquired by CIBC Bancorp USA Inc. - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Alecta Tjanstepension Omsesidigt - MarketBeat
AIA Group Ltd Has $19.06 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Thermo Fisher Scientific Inc. (TMO) carries a mid-single digit organic growth forecast - MSN
Thermo Fisher Scientific Inc. $TMO Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
Danske Bank A S Invests $123.22 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by CIBC Private Wealth Group LLC - MarketBeat
Thermo Fisher: A High-Quality Life Science Platform Positioned For Growth (NYSE:TMO) - Seeking Alpha
Avity Investment Management Inc. Has $20.82 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
131,645 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Danica Pension Livsforsikringsaktieselskab - MarketBeat
Thermo Fisher Scientific (TMO) Surged on Investors’ Optimism - Insider Monkey
National Bank of Canada FI Sells 41,297 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Gotham Asset Management LLC Reduces Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Holocene Advisors LP Invests $46.70 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific expands presence in Ireland with new Distribution Centre - BioMelbourne Network
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):